Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria
NCT03819647
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Hyperoxaluria
Interventions
DRUG:
stiripentol (Diacomit)
Sponsor
Biocodex